Non-Invasive Hemodynamic Whole-Body Bioimpedance Indices for the Early Detection of Cancer Treatment-Related Cardiotoxicity: A Retrospective Observational Study

Nili Schamroth Pravda, Shaul Lev , Osnat Itzhaki Ben Zadok, Ran Kornowski, Zaza Iakobishvili

Conclusion: GGI, a parameter measured by WBI, can reliably correlate to biomarker evidence of heart failure in patients after chemotherapy. Its use as a screening tool for cardiotoxicity in patients with ongoing anticancer therapy is promising.

For the full article click here

Contact Us

Stay updated with our monthly newsletter

We promise quality content and no spam! :)

Skip to content